NCT02135042 2026-03-18
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NRG Oncology
Phase 2/3 Active not recruiting
NRG Oncology
Hospital Moinhos de Vento
Rutgers, The State University of New Jersey
Alliance for Clinical Trials in Oncology
Uppsala University
Indiana University
City of Hope Medical Center
NRG Oncology
Fundacion IMIM
Erasmus Medical Center
City of Hope Medical Center
Guy's and St Thomas' NHS Foundation Trust
Rigshospitalet, Denmark